What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?
Within a year, the investing legend has doubled down on his latest pharma bet
Himanshu Kakkar - May 23, 2020
How Biocon has been leading from the front | Editor's Note
Kiran Mazumdar Shaw's bold biologics bet is set to reap rewards
N Mahalakshmi - April 25, 2020
Uphill Climb
The pharma industry has to deal with poor road connectivity and an unskilled labour force in Sikkim, but it seems to have made peace with the mountains
Himanshu Kakkar - January 25, 2019
Homesick
Rising chronic illnesses and increasing health insurance coverage will spur domestic pharma industry growth
January 02, 2018
Just what the doctor ordered
The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon
December 23, 2017
Under The Weather- Part 1
The domestic pharma industry, which is already battling the US FDA, has now to contend with regulatory challenges at home
Krishna Gopalan - May 20, 2017
Under The Weather - Part 2
Even as it battles the US FDA, the industry has been caught off-guard by policy changes back home
Krishna Gopalan - June 05, 2017